Skip to main content
Caplight Logo









Foxcroft Therapeutics, Inc.

Foxcroft Therapeutics, Inc.

Private
United StatesHealthcare & Life Scienceshttps://foxcrofttx.com/

Company Overview

Foxcroft Therapeutics, Inc. is a biotechnology company that develops targeted, tumor lysate–based cancer vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cancer vaccineimmuno-oncologylipid nanoparticleLNPtumor lysatedrug deliverybiotechpre-clinicaltherapeutic vaccineprecision medicinedrug discoverynext-gen vaccinesbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Foxcroft Therapeutics, Inc. Comparables

Compare Foxcroft Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Foxcroft Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hopewell Therapeutics
81%
AbbVie
69%
Eli Lilly and Company
61%

Foxcroft Therapeutics, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Foxcroft Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

Foxcroft Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Foxcroft Therapeutics, Inc.'s valuation, stock price, and market status.

Is Foxcroft Therapeutics, Inc. a public or private company?

Foxcroft Therapeutics, Inc. is a private company.

What is the current stock price of Foxcroft Therapeutics, Inc.?

Foxcroft Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Foxcroft Therapeutics, Inc. worth (valuation)?

Valuation information for Foxcroft Therapeutics, Inc. is not publicly available.

Can I buy Foxcroft Therapeutics, Inc. stock?

Foxcroft Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Foxcroft Therapeutics, Inc.'s last funding round?

Funding round information for Foxcroft Therapeutics, Inc. is not publicly available.

Who are the main investors in Foxcroft Therapeutics, Inc.?

Investor information for Foxcroft Therapeutics, Inc. is not publicly disclosed.

Will Foxcroft Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for Foxcroft Therapeutics, Inc..

How can I track Foxcroft Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Foxcroft Therapeutics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?